Track Vaso Corporation — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Vaso Corporation VASO · Stock Open Vaso Corporation in new tab

0.2900 USD
P/E
14.50
EPS
0.02
P/B
1.75
ROE
6.56
Beta
0.76
Loading chart...
Key Metrics
P/E14.50
EPS0.02
Book Value0.17
Price to Book1.75
Debt/Equity6.13
% Insiders43.890%
Growth
Revenue Growth0.08%
Earnings Growth-0.48%

DCF valuation

Model fair value for Vaso Corporation (VASO)
Result
Sign in to run the valuation for VASO.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–

Vaso Corporation Logo Vaso Corporation Analysis (VASO)

United States Health Care Official Website Stock

Is Vaso Corporation a good investment? Vaso Corporation (VASO) is currently trading at 0.2900 USD.

In terms of valuation, the stock trades at a P/E ratio of 14.50. This relatively low multiple may signal that Vaso Corporation is undervalued compared to historical market norms.

Investor FAQ

Does Vaso Corporation pay a dividend?

No, it does not currently pay a dividend.

What asset class is Vaso Corporation?

Vaso Corporation is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

Company Profile

Vaso Corporation, together with its subsidiaries, operates in the healthcare equipment and information technology industries in the United States and internationally. It operates in three segments: IT, Professional Sales Service, and Equipment. The IT segment primarily focuses on healthcare IT and managed network technology services. This segment offers managed network infrastructure, such as routers, switches, and other core equipment; managed network transport; and managed network security services. The Professional Sales Service segment principally focuses on the sale of healthcare capital equipment for General Electric Healthcare, Inc. (GEHC) into the health provider middle market. Its offerings include GEHC diagnostic imaging equipment and ultrasound systems, GEHC service agreements, GEHC training, and GEHC and third-party financial services. The Equipment segment primarily focuses on the design, manufacture, sale, and service of proprietary medical devices and software. This segment offers Biox series Holter monitors and ambulatory blood pressure recorders; ARCS series analysis, reporting, and communication software for ECG and blood pressure signals, including cloud-based software and algorithm subscription services; MobiCare multi-parameter wireless vital-sign monitoring systems; and Enhanced External Counterpulsation therapy systems for non-invasive and outpatient treatment of ischemic heart disease. The company was formerly known as Vasomedical, Inc. and changed its name to Vaso Corporation in November 2016. Vaso Corporation was incorporated in 1987 and is headquartered in Plainview, New York.

Exchange Ticker
PNK (United States) VASO
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
Dec. 16, 1991 1.15
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion